Trial · NCT01453049
Results by group150
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 150
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 24 | Rosiglitazone+Glimepiride FDC | -1.75 | Standard Deviation 1.078 | Percent of total hemoglobin | |
| Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 24 | Glimepiride | -1.47 | Standard Deviation 1.227 | Percent of total hemoglobin | |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24 | Rosiglitazone+Glimepiride FDC | -1.907 | Standard Deviation 2.9601 | Millimoles per liter (mmol/L) | |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24 | Glimepiride | -0.877 | Standard Deviation 2.0673 | Millimoles per liter (mmol/L) | |
| Number of HbA1c Responders and Non-responders | Rosiglitazone+Glimepiride FDC | Responders | 33 | participants | |
| Number of HbA1c Responders and Non-responders | Glimepiride | Responders | 29 | participants | |
| Number of HbA1c Responders and Non-responders | Rosiglitazone+Glimepiride FDC | Non-responders | 2 | participants | |
| Number of HbA1c Responders and Non-responders | Glimepiride | Non-responders | 9 | participants | |
| Number of FPG Responders and Non-responders | Rosiglitazone+Glimepiride FDC | Responders | 21 | participants | |
| Number of FPG Responders and Non-responders | Glimepiride | Responders | 12 | participants | |
| Number of FPG Responders and Non-responders | Rosiglitazone+Glimepiride FDC | Non-responders | 14 | participants | |
| Number of FPG Responders and Non-responders | Glimepiride | Non-responders | 26 | participants | |
| Number of Participants Who Achieved HbA1c <7%, HbA1c <=6.5%, or Who Achieved a Decrease of >=0.7% From Baseline | Rosiglitazone+Glimepiride FDC | HbA1c <7% | 13 | participants | |
| Number of Participants Who Achieved HbA1c <7%, HbA1c <=6.5%, or Who Achieved a Decrease of >=0.7% From Baseline | Glimepiride | HbA1c <7% | 13 | participants | |
| Number of Participants Who Achieved HbA1c <7%, HbA1c <=6.5%, or Who Achieved a Decrease of >=0.7% From Baseline | Rosiglitazone+Glimepiride FDC | HbA1c <=6.5% | 5 | participants | |
| Number of Participants Who Achieved HbA1c <7%, HbA1c <=6.5%, or Who Achieved a Decrease of >=0.7% From Baseline | Glimepiride | HbA1c <=6.5% | 8 | participants | |
| Number of Participants Who Achieved HbA1c <7%, HbA1c <=6.5%, or Who Achieved a Decrease of >=0.7% From Baseline | Rosiglitazone+Glimepiride FDC | HbA1c decrease of >=0.7% from Baseline | 33 | participants | |
| Number of Participants Who Achieved HbA1c <7%, HbA1c <=6.5%, or Who Achieved a Decrease of >=0.7% From Baseline | Glimepiride | HbA1c decrease of >=0.7% from Baseline | 29 | participants | |
| Change From Baseline in Fasting Proinsulin and Insulin at Week 24/Early Withdrawal (EW) | Rosiglitazone+Glimepiride FDC | Proinsulin; n=32, 34 | -2.9 | Standard Deviation 10.18 | Picomoles per liter (pmol/L) |
| Change From Baseline in Fasting Proinsulin and Insulin at Week 24/Early Withdrawal (EW) | Glimepiride | Proinsulin; n=32, 34 | 3.1 | Standard Deviation 10.70 | Picomoles per liter (pmol/L) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01453049/results